CBP issued the following releases on commercial trade and related matters:
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website Feb. 7, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
Starting March 1, non-industrial diamonds of 1 carat or greater, mined in Russia but with another country of origin cannot be entered into the U.S., whether by import or into a foreign-trade zone, unless the Office of Foreign Assets Control licensed that import.
Midway through the second term of solar safeguards, imports of solar panels (modules) and cells have been climbing, and the market has almost entirely shifted to bifacial solar panels, which were at first carved out of the safeguard. Whether a decision to revoke that exclusion in 2019 was legal is still being litigated (see 2311130031 and 2401290014).
The International Trade Commission published notices in the Feb. 7 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register Feb. 7 on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department has published the final results of the antidumping duty administrative review on xanthan gum from China (A-570-985). These final results will be used to set final assessments of AD on importers for subject merchandise entered July 1, 2021, through June 30, 2022.
On Feb. 6, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
U.S. Trade Representative Katherine Tai, speaking at the University of Chicago, sidestepped a question about whether the administration would change the Section 301 tariffs, saying that although "there's a lot of drama and emotion around tariffs," the China tariffs are "the least interesting aspect of the management of our trade and economic relationship."
Sen. Marco Rubio, R-Fla., is asking the head of the FDA why so many disposable e-cigarettes without FDA approval are entering the U.S.